- £189.73m
- £173.80m
- £113.34m
- 67
- 31
- 80
- 63
Annual income statement for Science, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 57.2 | 73.7 | 81.2 | 86.3 | 113 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 57.5 | 66.5 | 69.6 | 74.6 | 105 |
Operating Profit | -0.214 | 7.13 | 11.6 | 11.7 | 8.14 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.6 | 6.39 | 10.9 | 11.1 | 7.62 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.83 | 7.04 | 9.56 | 10.6 | 5.52 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.83 | 7.04 | 9.56 | 10.6 | 5.52 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.83 | 7.04 | 9.56 | 10.6 | 5.52 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.022 | 0.175 | 0.217 | 0.248 | 0.202 |
Dividends per Share |